9
Views
1
CrossRef citations to date
0
Altmetric
Research

Company Profile: Boehringer Ingelheim: Analysis of patenting 1992 - 1995

Pages 1-9 | Published online: 29 Feb 2008

References

  • STEELE P: Abbott analysis of patenting 1989-93. Exp. Opin. Ther. Patents (1994) 4(2): 99–108.
  • STEELE P: American Home Products Corp. (AHP): analy-sis of patenting 1989–1993. Esp. Opin. Ther. Patents(1994) 4(3): 207–215.
  • STEELE P: SmithKline Beecham analysis of patenting 1989-1993. E. Opin. Ther. Patents (1994) 4(4): 303–313.
  • STEELE P: Glaxo: analysis of patenting 1989-1993. Exp. Opin. Ther. Patents (1994) 4(5): 479–487.
  • STEELE P: Takeda: analysis of patenting 1989-1994. Exp. Opin. Ther. Patents (1994) 4(6): 611–619.
  • STEELE P: Rhone-Poulenc Rorer: analysis of patenting 1989-1994. Exp. Opin. Ther. Patents (1994)4(7): 751–760.
  • STEELE P: Schering Plough: analysis of patenting 1989-1994. Exp. Opin. Ther. Patents (1994) 4(8): 903–910.
  • STEELE P: Amgen, Inc.: analysis of patenting 1989–1994. Exp. Opin. Tiler. Patents (1994) 4(9): 1029–1035.
  • STEELE P: Merck & Co., Inc.: analysis of patenting 1991–1994. Exp. Opin. Ther. Patents(1994) 4(10): 1161–1172.
  • STEELE P: Hoechst: analysis of patenting 1991-1994. Exp. Opin. Tiger. Patents (1994) 4(11): 1309–1318.
  • STEELE P: F Hoffmann-la Roche Ltd.: analysis of patent-ing 1991–1994. Exp. Opin. Tiler. Patents (1994) 4(12): 1437–1444.
  • STEELE P: Bayer: analysis of patenting 1991-1994. Exp. Opin. Tber. Patents (1995) 5(1): 1–11.
  • STEELE P: Pfizer, Inc.: analysis of patenting 1989–1994. Exp. Opin. Ther. Patents (1995) 5(2): 99–110.
  • STEELE P: Wellcome: analysis of patenting 1991-1995. Exp. Opin. Ther. Patents (1995) 5(3): 191–198.
  • STEELE P: Johnson & Johnson: analysis of patenting 1991-1995. Exp. Opin. Ther. Patents (1995) 5(3): 199–210.
  • STEELE P: Zeneca: analysis of patenting 1991-1995. Exp. Opin. Ther. Patents (1995) 5(4): 277–285.
  • STEELE P: Ciba-Geigy: analysis of patenting 1991-1995. Exp. Opin. Ther. Patents (1995) 5(5): 381–389.
  • STEELE P: Bristol-Myers Squibb: analysis of patenting 1992-1995. Exp. Opin. Ther. Patents (1995) 5(6): 517–528.
  • STEELE P: Yamanouchi: analysis of patenting 1989-1995. Exp. Opin. Ther. Patents (1995) 5(7): 611–622.
  • STEELE P: Sandoz: analysis of patenting 1991-1995. Exp. Opin. Ther. Patents (1995) 5(8): 735–745.
  • STEELE P: Eli Lilly: analysis of patenting 1991-1995. Exp. Opin. Ther. Patents (1995) 5(9): 861–871.
  • STEELE P: Warner-lambert: analysis of patenting 1992-1995. Exp. Opin. Ther. Patents (1995) 5(10): 1015–1025.
  • STEELE P: Pharnaacia: analysis of patenting 1992-1995. Exp. Opin. Ther. Patents (1995) 5(11): 1147–1154.
  • STEELE P: Upjohn: analysis of patenting 1992–1995. Esp. Opin. 7ber. Patents 0995) 501): 1155–1161.
  • STEELE P: Sanal: analysis of patenting 1992-1995. Exp. Opin. Ther. Patents (1995) 5(12): 1259–1267.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.